Ceftriaxone Alone or in Combination with Antibiotics in the Management of Infection in Cancer Patients: A Review of 41 Clinical Trials Involving 7350 Patient-Episodes

By Venditti M.  

Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. : 195-210

Adis International

Access to resources Recommend Favorite

Capecitabine: A Review of its Use in the Treatment of Advanced or Metastatic Colorectal Cancer

By McGavin J.K.   Goa K.L.  

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2309-2326

Adis International

Access to resources Recommend Favorite

A Novel Combination of Cisplatin, Irinotecan, and Capecitabine in Patients with Advanced Cancer

By Jefford Michael   Michael Michael   Rosenthal Mark A.   Davis Ian D.   Green Michael   McClure Bev   Smith Jennifer   Waite Brigid   Zalcberg John  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

By Shin Sang  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 672-680

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

By Strickler John   McCall Shannon   Nixon Andrew   Brady John   Pang Herbert   Rushing Christel   Cohn Allen   Starodub Alexander   Arrowood Christy   Haley Sherri   Meadows Kellen   Morse Michael   Uronis Hope   Blobe Gerard   Hsu S.   Zafar S.   Hurwitz Herbert  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 330-339

Springer Publishing Company

Access to resources Recommend Favorite